Autologous hematopoietic cell transplantation for acute myeloid leukemia in adults: 25 years of experience in Japan-Reference-Cited by-同舟云学术

Autologous hematopoietic cell transplantation for acute myeloid leukemia in adults: 25 years of experience in Japan

Published:2019-10-14 Issue:1 Volume:111 Page:93-102
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Yanada Masamitsu^ORCID,Takami Akiyoshi,Mizuno Shohei,Mori Jinichi,Chou Takaaki,Usuki Kensuke,Uchiyama Hitoji,Amano Itsuto,Fujii Shiro,Miyamoto Toshihiro,Saito Takeshi,Kamimura Tomohiko,Ichinohe Tatsuo,Fukuda Takahiro,Okamoto Shinichiro,Atsuta Yoshiko,Yano Shingo

Funder

Japan Agency for Medical Research and Development

Aichi Cancer Research Foundation

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-019-02759-y.pdf

Reference44 articles.

1. Zittoun RA, Mandelli F, Willemze R, de Witte T, Labar B, Resegotti L, et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia: European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med. 1995;332:217–23.

2. Burnett AK, Goldstone AH, Stevens RM, Hann IM, Rees JK, Gray RG, et al. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial: UK Medical Research Council Adult and Children's Leukaemia Working Parties. Lancet. 1998;351:700–8.